PHARMACEUTICAL PREPARATIONS TREATEMENT
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| PARDYNA | Pfizer Inc. | 235 East 42nd Street New York NY 10017 | Pharmaceutical preparations for the treatement of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use;The wording PARDYNA has no meaning in a foreign language.; |
| RALACOX | Pfizer Inc. | 235 East 42nd Street New York NY 10017 | Pharmaceutical preparations for the treatement of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use;The wording RALACOX has no meaning in a foreign language.; |
| SALEXA | HEALTHPOINT, LTD. | 318 McCullough San Antonio TX 78215 | PHARMACEUTICAL PREPARATIONS FOR THE TREATEMENT OF SKIN CONDITIONS; |
Where the owner name is not linked, that owner no longer owns the brand |
Technical Examples
- The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.